Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

2.

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

3.

Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures

4.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

5.

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot